AAAnow, 25 years of innovation

The use cases · Pharmaceutical

Legacy document exposure.

Pharmaceutical organisations carry decades of published documents: trial summaries, product information, regulatory material.

Much of it is superseded; most of it is still reachable. AI systems read it with the same confidence as the current label, and repeat it in health contexts.

ReferenceUC/2026/07
Updated12 August 2026
SectorPharmaceutical
ExposureMisinformation, misrepresentation
Where it startsDocument archives

01Where it begins

Legacy PDFs and document archives remain available across corporate, product and market sites, beyond the reach of routine content management.

02How it compounds

Superseded safety, indication or dosing information repeated as current is a patient-safety and regulatory question, and correction is measured against an answer already established.

03What AI Readiness changes

AI Readiness brings the document estate into view, and under control.

Discovery

The document estate is discovered in full, with PDF benchmarking across everything found.

A governed position

The current position stands; superseded documents are identified and controlled.

Representation monitored

What AI systems repeat from the record is monitored against the governed position.

Next step

Talk it through, in your terms.

The briefing sets this exposure in your sector’s terms, and the discussion follows your questions.

Your briefing invite

An illustrative scenario. No client is referenced, and no organisation has been assessed.

Questions

The questions this scenario raises.

Asked by boards in this position, answered directly.

We retired that site years ago. Why is it still being read?

Retired rarely means removed. Old microsites, PDFs and subdomains stay live, mirrored or cached, and AI systems read them with no sense of retirement. Under your name, they are your current position until they are found and dealt with.

How much of this is out there?

More than the organisation's own records show; the unknown share of the digital footprint is consistently material. The collection stage, colleagues adding the sites they know, followed by grading, is how the real number replaces the guess.

What is route removal?

The disciplined retirement of what no longer earns its place: taken down, redirected or formally superseded, so machines stop treating it as current. It follows the landscape stage, so removals are evidence-led.

Can automated discovery find what nobody remembers?

Yes, as an option. AI discovery (option) engages after the known estate is collected and searches for what nobody thought to list. It extends the picture; it never substitutes for the organisation's own knowledge.